GlassScriptPhysician profile
Deanna Mantle
NPI 1194117671
$3,290.09
in general payments reported to CMS, 2019-2025
45 companies · $513 in 2025
The $513 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,312 · 2022: $485 · 2023: $704 · 2024: $276 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.98 |
| Education | $151.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $569.17 | 2021-2025 | |
| Janssen Biotech, INC. | $201.89 | 2024-2025 | Tremfya, Stelara |
| Novo Nordisk INC | $172.82 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $157.03 | 2023-2024 | |
| Abbott Laboratories | $150.87 | 2021-2023 | Infinity |
| Madrigal Pharmaceuticals | $129.52 | 2025 | Rezdiffra |
| Nestle Healthcare Nutrition INC. | $113.67 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $111.85 | 2023-2024 | Ocaliva |
| Biohaven Pharmaceuticals, INC. | $93.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.72 | 2022-2023 | Trulance, Xifaxan |
| Qol Medical, LLC | $88.72 | 2022-2023 | Sucraid |
| Allergan, INC. | $87.64 | 2021 | |
| Amgen INC. | $85.90 | 2021-2023 | Prolia, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $84.27 | 2022-2023 | Glassia |
| Regeneron Healthcare Solutions, INC. | $81.01 | 2022-2023 | Dupixent |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Mantle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.